Zimmer Partners’s Kronos Bio KRON Stock Holding History

Zimmer Partners’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,500	Closed	-$366K	–	198
2021 Q1	$366K	Hold	12,500	–	–	0.01%	163
2020 Q4	$373K	Buy	+12,500	New	+$392K	0.01%	121

Other funds holding KRON

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Zimmer Partners's KRON Position: Q2 2021 in Review

Zimmer Partners sold out of Kronos Bio (KRON) in Q2 2021, closing a stake of 12,500 shares — an estimated $366K sold.

Zimmer Partners first reported a position in KRON in Q4 2020 and held it in 2 quarters. The position peaked at $373K in Q4 2020. 77 funds tracked by Wall St. Rank hold KRON as of Q2 2021.

Zimmer Partners reported no remaining Kronos Bio position as of Q2 2021 after selling out during the quarter.
Zimmer Partners sold 12,500 Kronos Bio shares in Q2 2021, an estimated $366K.
Zimmer Partners first reported a position in Kronos Bio in Q4 2020 and held it in 2 quarters.
Zimmer Partners's Kronos Bio position peaked at $373K in Q4 2020.
77 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2021.

Based on Zimmer Partners's 13F filing for Q2 2021, filed 16 Aug 2021.